@inbook{bed27a32e1b74e64a318cd456044fbac,
title = "Novel Therapies on the Horizon",
abstract = "As many of the prior chapters illustrate, we have had many successes in the treatment of children with malignant bone tumors. Nevertheless, there is a substantial fraction of patients who are not cured by current therapies. In addition, even those who are long term survivors often suffer chronic side effects of treatment. Thus, we need to continue to explore novel therapies both to increase the cure rates and decrease complications. In this chapter we review available data for a variety of new therapies including novel small molecules, immunotherapies, and virotherapy, with an emphasis on fi ndings in preclinical models or early phase clinical trials in patients with bone cancers.",
author = "Cripe, \{Timothy P.\} and Haworth, \{Kellie B.\} and Houghton, \{Peter J.\}",
note = "Publisher Copyright: {\textcopyright} Springer International Publishing Switzerland 2015.",
year = "2015",
doi = "10.1007/978-3-319-18099-1\_15",
language = "English (US)",
series = "Pediatric Oncology",
publisher = "Springer Science and Business Media Deutschland GmbH",
pages = "265--291",
booktitle = "Pediatric Oncology",
address = "Germany",
}